Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2025

Soligenix Inc. (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent Need for Alternatives to Antibiotics

Posted on May 23, 2025 by MissionIR

In the face of escalating antibiotic resistance, the medical community is urgently seeking alternative treatments for bacterial infections. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is at the forefront of this effort with its development of SGX943 (dusquetide), a novel broad-spectrum … Continue reading →

Posted in Soligenix Inc. SNGX | Leave a comment

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Posted on May 23, 2025 by MissionIR

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics, Inc., a medical and technology-driven company, are expanding their footprint in the mental health care sector with the acquisition of Kadima Neuropsychiatry Institute in La … Continue reading →

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

FAVO Capital Inc. (FAVO): Positioned to Capitalize on Small Business Lending Revival

Posted on May 23, 2025 by MissionIR

As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market in the process. With policymakers calling for renewed focus on small business financing and digital platforms … Continue reading →

Posted in FAVO Capital Inc. FAVO | Leave a comment

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows

Posted on May 23, 2025 by MissionIR

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, is preparing for its expected U.S. launch in 2025, as it is progressing through the FDA clearance process for its Intelligent Fingerprinting Drug Screening System. … Continue reading →

Posted in Intelligent Bio Solutions Inc. INBS | Leave a comment

MissionIRNewsBreaks – Soligenix Inc.’s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results in Rare Cancer Trial

Posted on May 22, 2025 by MissionIR

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell lymphoma (“CTCL”), a rare form of cancer that affects the skin. “Soligenix’s proprietary treatment, HyBryte(TM), is currently … Continue reading →

Posted in Soligenix Inc. SNGX | Leave a comment

MissionIRNewsBreaks – Precision Meets Performance: Newton Golf Company Inc.’s (NASDAQ: NWTG) Fitted Shafts Elevate the Game

Posted on May 22, 2025 by MissionIR

Newton Golf Company (NASDAQ: NWTG) is revolutionizing golf performance through its high-quality, custom-fitted shafts engineered to match individual swing dynamics. Recognizing the shaft as the “engine” of the club, Newton leverages advanced technology to optimize swing speed, ball trajectory and overall … Continue reading →

Posted in Newton Golf Comp. NWTG | Leave a comment

Nutriband Inc. (NASDAQ: NTRB) Charts Path to Commercialization

Posted on May 22, 2025 by MissionIR

In a recent report to shareholders, Nutriband (NASDAQ: NTRB) CEO Gareth Sheridan shared significant company achievements and milestones as well as his expectations for 2025 (https://ibn.fm/9K5zT). At the center of the company’s positive outlook for future is noteworthy progress made toward the … Continue reading →

Posted in Nutriband Inc. NTRB | Leave a comment

FAVO Capital Inc. (FAVO): Filling the Financing Gap for Underserved SMBs

Posted on May 22, 2025 by MissionIR

With over 5.5 million new business applications filed in the U.S. last year alone, small- to medium-sized businesses (“SMBs”) are thriving, but many are finding themselves underserved by traditional financial institutions. According to recent industry insights, 6 in 10 SMBs … Continue reading →

Posted in FAVO Capital Inc. FAVO | Leave a comment

MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Wall Street Conference on May 21

Posted on May 21, 2025 by MissionIR

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx is one of six companies … Continue reading →

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

FAVO Capital Inc. (FAVO) Delivering Funding Solutions in Private Credit Market, Poised for Significant Growth

Posted on May 20, 2025 by MissionIR

The private credit market is on the cusp of substantial expansion in 2025, driven by a resurgence in global mergers and acquisitions (“M&A”), the digitization of lending processes and the emergence of innovative financing solutions tailored for small and medium-sized … Continue reading →

Posted in FAVO Capital Inc. FAVO | Leave a comment